Hypertension, the adrenal and the kidney: lessons from pharmacologic interruption of the renin-angiotensin system.
D000311:Adrenal Glands / Q000503:physiopathology*; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000450:Aldosterone / Q000097:blood; D000804:Angiotensin II / Q000502:physiology; D000809:Angiotensins / Q000502:physiology*; D000818:Animals; D001794:Blood Pressure; D004195:Disease Models, Animal; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology*; D006977:Hypertension, Renal / Q000503:physiopathology; D006978:Hypertension, Renovascular / Q000175:diagnosis / Q000503:physiopathology; D007668:Kidney / Q000503:physiopathology*; D012083:Renin / Q000502:physiology*; D012504:Saralasin; D013722:Teprotide
D000319:Adrenergic beta-Antagonists; D000809:Angiotensins; D000804:Angiotensin II; D000450:Aldosterone; D013722:Teprotide; D012083:Renin; D012504:Saralasin; D006854:Hydrocortisone